Recent Finacing
Recent Raise
Avro Life Science develops polymer-based transdermal patches using heat-triggered micro-adhesive bubbles to deliver hundreds of drugs (first: loratadine), targeting drugs with poor oral bioavailability or high liver toxicity.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
